Barinthus Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-9,173 | $14,969 |
Gross Profit | -2,024 | -2,041 | -12,071 | 14,969 |
EBITDA | -19,138 | -17,633 | -19,148 | -6,640 |
EBIT | -21,139 | -19,667 | -20,575 | -8,130 |
Net Income | -21,124 | -19,648 | -20,530 | -8,114 |
Net Change In Cash | 0 | 0 | -9,173 | 14,969 |
Free Cash Flow | -18,141 | -14,907 | 5,936 | -11,433 |
Cash | 86,259 | 99,118 | 110,662 | 106,102 |
Basic Shares | 40,343 | 40,265 | 39,348 | 39,419 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $14,969 | $802 | $44,703 | $268 |
Gross Profit | 14,969 | -4,645 | 44,703 | 268 |
EBITDA | -55,374 | -71,065 | 6,404 | -47,870 |
EBIT | -61,174 | -76,515 | 2,081 | -48,471 |
Net Income | -61,074 | -73,347 | 5,342 | -50,865 |
Net Change In Cash | 14,969 | 802 | 44,703 | 268 |
Cost of Revenue | 177,247 | |||
Free Cash Flow | -29,832 | -56,338 | -20,569 | -33,729 |
Cash | 110,662 | 142,090 | 194,385 | 214,054 |
Basic Shares | 39,348 | 38,386 | 38,169 | 37,189 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.52 |
2025-03-31 | -$0.49 |
2024-12-31 | -$0.20 |
